Rituximab in AChR subtype of myasthenia gravis: systematic reviewVincenzo Di Stefano, Carmelo Rodolico, Antonino Lupica et al.|Journal of Neurology Neurosurgery & Psychiatry|2020Cited by 86
Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndromeVincenzo Di Stefano, Filippo Brighina, Paolo Alonge et al.|Journal of Neurology|2023Cited by 52
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and ShadowsClaudia Vinciguerra, Vincenzo Di Stefano, Liliana Bevilacqua et al.|Brain Sciences|2023Cited by 47
Comorbidity in myasthenia gravis: multicentric, hospital-based, and controlled study of 178 Italian patientsVincenzo Di Stefano, Filippo Brighina, Salvatore Iacono et al.|Neurological Sciences|2024Cited by 46
Evidence-based guidelines for the pharmacological treatment of migraineRaffaele Ornello, Ilaria Orologio, Valeria Caponnetto et al.|Cephalalgia|2025Cited by 44